In the review by Chi-Un Pae and Ashwin A Patkar, Paroxetine: current status in psychiatry, published in the February 2007 issue of Expert Review of Neurotherapeutics (Expert Rev. Neurotherapeutics 7[2], 107–120 [2007]), the original text on page 111 reads:
GlaxoSmithKline’s recent letter to doctors points to a sixfold increase in the risk of suicidal behavior in adults taking paroxetine [104]; 32% (11 out of 3455) treated with paroxetine attempted suicide compared with 0.05% (one out of 1978) treated with placebo (OR: 6.7; 95% CI: 1.1–149.4).
The following figures on pages 112 and 115, respectively, show:
The corrected text should read:
GlaxoSmithKline’s recent letter to doctors points to a sixfold increase in the risk of suicidal behavior in adults taking paroxetine [104]; 0.32% (11 out of 3455) treated with paroxetine attempted suicide compared with 0.05% (one out of 1978) treated with placebo (OR: 6.7; 95% CI: 1.1–149.4).
The correct figures are given below:
The editors of Expert Review of Neurotherapeutics would like to sincerely apologize for any inconvenience or confusion the numbering error in this figure footnote may cause our readers.